AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. From Wikipedia
The Phase 3 result positions the TROP2‑targeting ADC for regulatory filings, potentially shifting first‑line care for patients who cannot receive immunotherapy.
